Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Key Decisions in HIV Care: Considering Rapid ART in a Patient With Opioid Use Disorder

Source: Key Decisions in HIV Care
Listen as Jason Halperin, MD, MPH, and his patient share their perspectives on why it’s important to rapidly initiate ART and provide treatment for OUD at the same time.
Jason Halperin, MD, MPH
Released: September 23, 2021

In this episode, Jason Halperin, MD, MPH, explores the data to support rapid ART initiation in patients with OUD.

Listen as he gives his perspectives on:

  • DHHS guidelines for rapid initiation of ART and specific recommendations for patients with substance use disorders
  • SAMSHA recommendations for the treatment of OUD  
  • Medications that are recommended for the treatment of OUD, including drug–drug interaction considerations with ART
  • Data to support the treatment of OUD to improve HIV viral suppression rates  

In addition, hear his patient’s perspective on the importance of receiving treatment for his OUD and HIV together. 

Information on this Educational Activity

Faculty

Jason Halperin, MD, MPH

Assistant Professor of Medicine
Department of Infectious Diseases
Tulane University
Infectious Disease Physician
CrescentCare
New Orleans, Louisiana

Jason Halperin, MD, MPH, has no relevant conflict of interest to report.

Program Medium

This program has been made available online.

Acknowledgements

Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Related Content

Expert selections of important HIV data from IDWeek 2021, including current and investigational ART, HIV PrEP, and metabolic outcomes of ART.

Eric S. Daar, MD Darcy Wooten, MD Released: October 19, 2021

Concise Clinical Care Options (CCO) presentation by Nicholas Chamberlain, MD, on investigational HIV PrEP strategies in various stages of development

Nicholas Chamberlain, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: October 15, 2021 Expired: October 14, 2022

Clinical Care Options (CCO) slides from Nicholas Chamberlain, MD, on investigational HIV PrEP strategies in various stages of development

Nicholas Chamberlain, MD Released: October 15, 2021

Perspective on continuation of BIC/FTC/TAF in suppressed patients who become pregnant, from Clinical Care Options (CCO) and Dr. William R. Short

William R. Short, MD, MPH, AAHIVS Released: October 15, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue